Clicky

China Medical System Holdings Limited(2M7C)

Description: China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China. Its products include VALTOCO, a diazepam nasal spray to treat seizure clusters; Plendil for the treatment of hypertension and stable angina pectoris; XinHuoSu to treat acute heart failure; Deanxit for mild-to-moderate depression, anxiety, and psychosomatic affections; METOJECT, a methotrexate injection for recalcitrant disabling psoriasis; and Ursofalk for the treatment of cholesterol gallstones in the gallbladder, cholestatic liver disease, and biliary reflux gastritis. The company also offers Salofalk for treating Ulcerative Colitis and Crohn's disease; Bioflor for the treatment of diarrhea; Combizym for dyspepsia; ILUMETRI, a tildrakizumab injection to treat moderate-tosevere plaque psoriasis; Augentropfen Stulln Mono eye drops to treat senile macula degeneration and asthenopia; and Hirudoid for blunt traumata with or without hematomas and superficial phlebitis insofar. In addition, it provides Aethoxysklerol for sclerotherapy of different varicose veins; Heling Soothing product for skin soothing; Vmonalisa for mid to deep dermal implantation; Neauvia Hyaluronic Acid series; EyeOP1 to treat glaucoma; Ganfule capsules for the treatment of primary cancer of the liver; Imdur for the treatment of coronary heart disease, chronic heart failure, and myocardial infarction, as well as for prevention of vasospasm and mixed angina; MOVICOL for treating chronic constipation and faecal impaction; and MeteoSpasmyl to treat gastrointestinal flatulence and pain. The company was founded in 1995 and is headquartered in North Point, Hong Kong. China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited.


Keywords: Pharmaceutical Products Pain Monoclonal Antibodies Hypertension Psoriasis Ulcerative Colitis Glaucoma Crohn's Disease Diarrhea Heart Disease Hyaluronic Acid Vascular Surgery Angina Seizure Coronary Artery Disease Myocardial Infarction Treatment Of Hypertension Chronic Heart Failure Coronary Heart Disease Methotrexate Acute Heart Failure Chronic Constipation Asthenopia Cholestasis Treatment Of Diarrhea Biliary Reflux Gastritis Cholestatic Liver Disease Cholesterol Gallstones Mixed Angina Salofalk Stable Angina Pectoris Superficial Phlebitis Treatment Of Coronary Heart Disease Ursofalk Varicose Veins Imdur Mild To Moderate Depression Plendil Primary Cancer Treatment Of Primary Cancer

Home Page: web.cms.net.cn/zh/home/

Island Place Tower
North Point,
Hong Kong
Phone: 852 2369 7678


Officers

Name Title
Mr. Kong Lam Founder, Chairman, CEO & President
Ms. Yanling Chen CFO, VP & Executive Director
Mr. Hongbing Chen COO, VP, Director of Sales & Marketing and Executive Director
Ms. Sanyan Wu Director of Legal Department & Company Secretary
Dr. Huaizheng Peng M.D., Ph.D. Chief Business Officer
Mr. Fei Jiang Chief Investment Officer of Greater China
Mr. James Patrick Stearns Chief Investment Officer of Europe & America

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 8.0841
Trailing PE: 13.3571
Price-to-Book MRQ: 1.0911
Price-to-Sales TTM: 0.325
IPO Date:
Fiscal Year End: December
Full Time Employees: 5781
Back to stocks